Home > 
News
Print

21 February 2012 - Antibodies against a pancreatic specific biomarker


Anti-hFXYD2γa antibodies are purified antibodies reacting with high sensitivity and high specificity with a 11 amino-acid residue peptide of FXYD2γa allowing early identification of human pancreatic β-cell and the follow up of therapies for diabetes.

FXYD2γa is a regulating subunit of the NA+-K+-ATPase identified as β-cell-specific biomarker.
Back to news list

To receive relevant information on our products, you should first select your country :
Country selection page

Feedback Form